AI-generated illustrative photograph representing the Healthcare & Pharmaceuticals sector

Industries We Serve

Healthcare & Pharmaceuticals

Helping Healthcare Organisations Deliver Growth with Compliance and Confidence

Industry Overview

Helping Healthcare Organisations Deliver Growth with Compliance and Confidence

India’s healthcare and life sciences sector is evolving rapidly, driven by digital transformation, increasing private investment, expanding healthcare infrastructure and a stronger regulatory focus on quality, governance and patient outcomes.

At Mehra Goel & Co., we work alongside healthcare providers, pharmaceutical companies, diagnostics chains, medical device businesses, digital health enterprises and healthcare investors to deliver multidisciplinary advisory solutions across taxation, assurance, transaction advisory, regulatory compliance, risk management and business consulting.

Whether you are establishing a new healthcare facility, expanding operations, undertaking mergers and acquisitions, attracting investment or strengthening compliance frameworks, our Partner-led approach delivers practical advice at every stage of your growth journey.

Why Healthcare & Pharmaceuticals Businesses Choose Us

  • Taxation and regulatory advisory for healthcare and life sciences businesses
  • Assurance, internal audit and financial reporting
  • Transaction advisory, due diligence and investment support
  • GST, corporate tax and international tax advisory
  • Risk management, governance and compliance framework development
  • FEMA and cross-border structuring
  • Business restructuring, expansion and strategic advisory

Need expert advice for your business?

Talk to our industry specialists for personalised solutions.

Contact Us

Recent Industry Developments (2026)

What’s Shaping the Sector

  • Expansion of the Ayushman Bharat Digital Mission (ABDM) is accelerating digital health records and interoperability.
  • Healthcare AI adoption is growing in diagnostics, hospital operations and clinical decision support.
  • Medical device manufacturing continues to receive policy support under the PLI scheme.
  • Private equity and strategic investment remain strong across hospitals, diagnostics and health technology.
  • Quality accreditation and governance continue to gain prominence across providers.
  • Cross-border collaborations and contract research are expanding, with new tax and compliance requirements.
Corporate skyline, representing global reach

Don’t See Your Sector Listed?

These Are Our Core Sectors — Not Our Only Ones.

If your industry has a regulator, we’ve probably already worked with one of its filers.